Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 14;18(10):5223.
doi: 10.3390/ijerph18105223.

An Interaction Effect Analysis of Thermodilution-Guided Hemodynamic Optimization, Patient Condition, and Mortality after Successful Cardiopulmonary Resuscitation

Enikő Kovács  1 , Valéria Anna Gyarmathy  2   3 , Dávid Pilecky  4 , Alexandra Fekete-Győr  5 , Zsófia Szakál-Tóth  6 , László Gellér  6 , Balázs Hauser  1 , János Gál  1 , Béla Merkely  6 , Endre Zima  6
Affiliations

An Interaction Effect Analysis of Thermodilution-Guided Hemodynamic Optimization, Patient Condition, and Mortality after Successful Cardiopulmonary Resuscitation

Enikő Kovács et al. Int J Environ Res Public Health. .

Abstract

Proper hemodynamic management is necessary among post-cardiac arrest patients to improve survival. We aimed to investigate the effects of PiCCO™-guided (pulse index contour cardiac output) hemodynamic management on mortality in post-resuscitation therapy. In this longitudinal analysis of 63 comatose patients after successful cardiopulmonary resuscitation cooled to 32-34 °C, 33 patients received PiCCO™, and 30 were not monitored with PiCCO™. Primary and secondary outcomes were 30 day and 1 year mortality. Kaplan-Meier curves and log-rank tests were used to assess differences in mortality among the groups. Interaction effects to disentangle the relationship between patient's condition, PiCCO™ application, and mortality were assessed by means of Chi-square tests and logistic regression models. A 30 day mortality was significantly higher among PiCCO™ patients, while 1 year mortality was marginally higher. More severe patient condition per se was not the cause of higher mortality rate in the PiCCO™ group. Patients in better health conditions (without ST-elevation myocardial infarction, without cardiogenic shock, without intra-aortic balloon pump device, or without stroke in prior history) had worse outcomes with PiCCO™-guided therapy. Catecholamine administration worsened both 30 day and 1 year mortality among all patients. Our analysis showed that there was a complex interaction relationship between PiCCO™-guided therapy, patients' condition, and 30 day mortality for most conditions.

Keywords: cardiac arrest; hemodynamic monitoring; hypothermia; mortality; resuscitation; thermodilution.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interest.

Figures

Figure 1
Figure 1
The selection of study population and eligibility of patients. A total of 254 patients after successful cardiopulmonary resuscitation were screened, and 63 were included into the study based on the inclusion and exclusion criteria. N: number of patients; PiCCO™: pulse index contour cardiac output.
Figure 2
Figure 2
(A). Hemodynamic management of patients in PiCCO™ group in the case of low (<3 L/min/m2) cardiac index. (B). Hemodynamic management of patients in PiCCO™ group in the case of normal or high (>3 L/min/m2) cardiac index. SVRI: systemic vascular resistance index.
Figure 3
Figure 3
Cumulative incidence of 30 day and 1 year mortality by PiCCO status. Kaplan–Meier curves and log-rank tests were performed. p: level of significance; and PiCCO: pulse index contour cardiac output.
Figure 4
Figure 4
Comparison of PiCCO use, 30 day mortality, and 1 year mortality by patient condition characteristics. Chi-square test was performed. ∗: p < 0.05; #: p < 0.2; PiCCO: pulse index contour cardiac output; IABP: intra-aortic balloon pump; PCI: percutaneous coronary intervention; and STEMI: ST-elevation myocardial infarction.
Figure 5
Figure 5
Interaction effects between PiCCO™-application, 30 day mortality, and patient condition characteristics. Patient conditions are depicted in the different subfigures; (a) hyperlipidemia; (b) STEMI at admission; (c): PCI treatment; (d): cardiogenic shock at admission; (e): IABP insertion; (f): catecholamine administration; (g): stroke in the prior history. Crude and adjusted logistic regressions were performed. In the crude models, all the interaction term dummy variables were included as separate variables. In the adjusted models, non-significant dummies were combined. ∗: p < 0.05; #: p < 0.2; catechol: catecholamine; CS: cardiogenic shock; HLP: hyperlipidemia; IABP: intra-aortic balloon pump; N: number of patients; PCI: percutaneous coronary intervention; PiCCO: pulse index contour cardiac output; and STEMI: ST-elevation myocardial infarction.
Figure 6
Figure 6
Interaction effects between PiCCO™-application, 1 year mortality, and patient condition characteristics. Patient conditions are depicted in the different subfigures; (a) hyperlipidemia; (b) STEMI at admission; (c): PCI treatment; (d): cardiogenic shock at admission; (e): IABP insertion; (f): catecholamine administration; (g): stroke in the prior history. Crude and adjusted logistic regressions were performed. In the crude models, all the interaction term dummy variables were included as separate variables. In the adjusted models, non-significant dummies were combined. ∗: p < 0.05; #: p < 0.2; catechol: catecholamine; CS: cardiogenic shock; HLP: hyperlipidemia; IABP: intra-aortic balloon pump; N: number of patients; PCI: percutaneous coronary intervention; PiCCO: pulse index contour cardiac output; and STEMI: ST-elevation myocardial infarction.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Grasner J.T., Wnent J., Herlitz J., Perkins G.D., Lefering R., Tjelmeland I., Koster R.W., Masterson S., Rossell-Ortiz F., Maurer H., et al. Survival after out-of-hospital cardiac arrest in Europe—Results of the EuReCa TWO study. Resuscitation. 2020;148:218–226. doi: 10.1016/j.resuscitation.2019.12.042. - DOI - PubMed
    1. Kiguchi T., Okubo M., Nishiyama C., Maconochie I., Ong M.E.H., Kern K.B., Wyckoff M.H., McNally B., Christensen E.F., Tjelmeland I., et al. Out-of-hospital cardiac arrest across the World: First report from the International Liaison Committee on Resuscitation (ILCOR) Resuscitation. 2020;152:39–49. doi: 10.1016/j.resuscitation.2020.02.044. - DOI - PubMed
    1. Perkins G.D., Handley A.J., Koster R.W., Castren M., Smyth M.A., Olasveengen T., Monsieurs K.G., Raffay V., Grasner J.T., Wenzel V., et al. European Resuscitation Council Guidelines for Resuscitation 2015: Section 2. Adult basic life support and automated external defibrillation. Resuscitation. 2015;95:81–99. doi: 10.1016/j.resuscitation.2015.07.015. - DOI - PubMed
    1. Nolan J.P., Neumar R.W., Adrie C., Aibiki M., Berg R.A., Bottiger B.W., Callaway C., Clark R.S., Geocadin R.G., Jauch E.C., et al. Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscitation. 2008;79:350–379. doi: 10.1016/j.resuscitation.2008.09.017. - DOI - PubMed
    1. Nolan J.P., Soar J., Cariou A., Cronberg T., Moulaert V.R., Deakin C.D., Bottiger B.W., Friberg H., Sunde K., Sandroni C. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for Post-resuscitation Care 2015: Section 5 of the European Resuscitation Council Guidelines for Resuscitation 2015. Resuscitation. 2015;95:202–222. doi: 10.1016/j.resuscitation.2015.07.018. - DOI - PubMed